The findings from the present study suggest that a decrease in adropin and rise in afamin may potentially serve as futuristic predictors for the deterioration of renal function and may be involved in the pathological mechanisms of CKD and its associated complications such as CKD-MBD and high lipid levels. This evidence concerns the gene AFM and chronic kidney disease.